secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2022-05-05T23:59:59+00:00
Accession:  0001628280-22-012714
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CFO Scott Dalgleish departs April 29; enters consulting pact through May 31, 2022
--------------------------------------------------------------------------------

- CFO Scott Dalgleish's last employment date was April 29, 2022; consulting agreement effective April 30 to May 31, 2022.
- Consulting agreement allows continued vesting of up to 15,183 stock options; exercise period extended to Dec 31, 2022.
- Separation and consulting terms described as ordinary course transition; no replacement named.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000162828022012714/0001628280-22-012714-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000162828022012714/toi-20220429.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-012714

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer